Objectives: This study sought to examine the frequency of indications for and the immediate
and long-term clinical outcomes of transcatheter closure of patent foramen ovale (PFO) …

Objectives: The present study was conducted to determine the safety of the transcatheter
closure of a patent foramen ovale (PFO) in patients with cryptogenic cerebral ischemia and …

Objectives To describe medium‐to long‐term follow‐up of patients undergoing device
closure of patent foramen ovale (PFO) for stroke or transient ischemic attack (TIA) …

ABSTRACT Background: Patent Foramen Ovale (PFO) occurs in approximately 25% of the
population and has been implicated in the etiology of cryptogenic stroke. Although the exact …

Aims Observational studies favor percutaneous closure of patent foramen ovale (PFO) over
medical therapy to reduce the risk of recurrent stroke, whereas randomized clinical trials …

Objectives To evaluate the safety and efficacy of percutaneous device closure of patent
foramen ovale (PFO) for secondary prevention of ischemic stroke Background Stroke …

Background Patent foramen ovale (PFO) closure is the gold standard for treating patients
with cryptogenic stroke and PFO. However, scarce data exist on the long-term outcomes …

BACKGROUND: Transcatheter closure of patent foramen ovale (PFO) has rapidly evolved
as the preferred management strategy for the prevention of recurrent cerebrovascular events …

Aims: Residual shunt following percutaneous patent foramen ovale (PFO) closure has been
described in up to 49% of patients and is associated with recurrent cerebrovascular events …

Objectives To determine the incidence of symptomatic recurrent embolic events after patent
foramen ovale (PFO) closure and potential causes for these events. Background It is well …